Heat treated during growth phase for stable survival in the body
First developed and established in Japan
Immuno-LP20™ is the first natural immunobiotic to emerge on the world market. Already established in Japan where it was developed by Japanese scientists, Immuno-LP20 is a heat-killed strain of Lactobacillus plantarum (L-137), a lactic acid bacteria commonly found in a wide variety of fermented foods. As a live organism, L. plantarum is considered a beneficial probiotic; but its immune-supporting benefits are inhibited by its structure and lack of stability within digestive fluid. Immuno-LP20 is heat treated at a precise moment during the growth phase to break down the cell membrane and components, eliminating the inhibitors and stabilising the product for survival in the gastric fluids. This allows for a powerful stimulating effect on the production of IL-12, an important factor in immune system function.
Research shows that Immuno-LP20 is active within the small intestine, where it passes through the intestinal lumen to stimulate production of IL-2 and IFN-β. IL-12 in turn, produces T cells and activates effector cells such as NK cells and CTLs. IFN-β is one of the most important cytokines directly involved in immune defence.
Keep all supplements out of sight and reach of young children. Do not exceed the stated recommended intake. Content on this site is not intended to substitute advice given by a medical practitioner, pharmacist, or other licensed health-care professional. Contact your health-care provider immediately if you suspect that you have a medical condition. These products are not intended to be used to diagnose, treat, cure, or prevent any disease or health condition. Food supplements must not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Adverse reactions to supplements are rare, but if you experience an adverse reaction stop taking the product and contact your practitioner. Sometimes a supplement will suit one person but not another.